✦ LIBER ✦

Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancer

✍ Scribed by Ilenia Migliaccio; Meng-Fen Wu; Carolina Gutierrez; Luca Malorni; Syed K. Mohsin; D. Craig Allred; Susan G. Hilsenbeck; C. Kent Osborne; Heidi Weiss; Adrian V. Lee

Book ID: 106378486
Publisher: Springer US
Year: 2009
Tongue: English
Weight: 588 KB
Volume: 123
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-009-0632-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular markers for predicting respons

Molecular markers for predicting response to tamoxifen in breast cancer patients

✍ Daniel R. Ciocca; Richard Elledge 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 102 KB

AQP5 Expression Predicts Survival in Pat

AQP5 Expression Predicts Survival in Patients with Early Breast Cancer

✍ Lee, Soo Jung; Chae, Yee Soo; Kim, Jong Gwang; Kim, Wan Wook; Jung, Jin Hyang; P 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 312 KB

BRCA1promoter methylation status does no

BRCA1promoter methylation status does not predict response to tamoxifen in sporadic breast cancer patients

✍ Jasmina Z. Cerne, Lin Zong, Jaroslav Jelinek, Susan G. Hilsenbeck, Tao Wang, Ste 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 318 KB

Redox Protein Expression Predicts Radiot

Redox Protein Expression Predicts Radiotherapeutic Response in Early-Stage Invasive Breast Cancer Patients

✍ Haffty, B.G. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Does c-erbB2/HER2 overexpression predict

Does c-erbB2/HER2 overexpression predict adjuvant tamoxifen failure in patients with early breast cancer?

✍ J.C.C. Hu; K. Mokbel 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Cyclin D1 overexpression is a negative p

Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients

✍ Stendahl, M; Kronblad, Å; Rydén, L; Emdin, S; Bengtsson, N O; Landberg, G 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 121 KB